Back to Search
Start Over
Update on capecitabine alone and in combination regimens in colorectal cancer patients.
- Source :
- Cancer Treatment Reviews; Nov2010, Vol. 36, pS46-S55, 0p
- Publication Year :
- 2010
-
Abstract
- SUMMARY: Capecitabine is an orally administered fluoropyrimidine carbamate which has been developed as a prodrug of 5-FU with the goal to improve its tolerability and intratumoral drug concentration. The review aims to provide an evidence-based update of clinical trials investigating the clinical efficacy, adverse-event profile, dosage and administration of this drug, alone or in combination with conventional chemotherapeutics and/or new target-oriented drugs, in the management of colorectal cancer patients. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 03057372
- Volume :
- 36
- Database :
- Supplemental Index
- Journal :
- Cancer Treatment Reviews
- Publication Type :
- Academic Journal
- Accession number :
- 55673688
- Full Text :
- https://doi.org/10.1016/S0305-7372(10)70020-7